A.J. Day's guest appearances

A.J. Day

The Mortar & Pestle

Jim Smith

David Glasser

Anna Cabeca

Michael Jones

Matt Martin

Pam Smith

Stephanie Allen

Lindsey Berkson

Peter Koshland

Nat Jones

Dylan Herr

Gus Bassani

Steve Hoffart

Haley Collavo

Roxanne Carfora

OwlTail

 A.J. Day, PharmD, Vice President of Clinical Services at PCCA, joins co-hosts Mike De Lisio and Sebastian Denison, RPh, FAARM (candidate), to discuss the current regulatory environment within the compounding industry and discusses how the environment could potentially impact all compounding pharmacists.

A.J. Day, PharmD, Vice President of Clinical Services at PCCA, joins co-hosts Mike De Lisio and Sebastian Denison, RPh, FAARM (candidate), to discuss the current regulatory environment within the compounding industry and discusses how the environment could potentially impact all compounding pharmacists.

The Latest Pharmacy Compounding Regulatory Happenings with A.J. Day

A.J. Day, PharmD, PCCA Vice President of Clinical Services, and Matt Martin, PharmD, PCCA Clinical Compounding Pharmacist, join co-hosts Mike De Lisio and Sebastian Denison, RPh. They discuss the recently revised USP General Chapter  and how it may affect pharmacies that compound nonsterile preparations. Make sure to listen to this episode and read the newly released Chapter , which goes into effect on December 1, 2019.

A.J. Day, PharmD, PCCA Vice President of Clinical Services, and Matt Martin, PharmD, PCCA Clinical Compounding Pharmacist, join co-hosts Mike De Lisio and Sebastian Denison, RPh. They discuss the recently revised USP General Chapter and how it may affect pharmacies that compound nonsterile preparations. Make sure to listen to this episode and read the newly released Chapter , which goes into effect on December 1, 2019.

The New USP 795 with A.J. Day & Matt Martin

A.J. Day, PharmD, PCCA Vice President of Clinical Services, joins Mike and Sebastian to discuss various details of federal oversight on 503A compounding as well as an important FDA ruling on several bulk substances related to compounding for human use, which goes into effect on March 21, 2019. 

A.J. Day, PharmD, PCCA Vice President of Clinical Services, joins Mike and Sebastian to discuss various details of federal oversight on 503A compounding as well as an important FDA ruling on several bulk substances related to compounding for human use, which goes into effect on March 21, 2019.